To squeeze or not to squeeze. The ARISE-FLUIDS trial
This review discusses the ARISE-FLUIDS trial, which directly compared two distinct resuscitation strategies in septic shock patients presenting to the emergency department. One arm involved initiating vasopressors early alongside restricted fluid administration, while the other utilized higher initial fluid volumes with later vasopressor initiation. The primary finding reported is that neither of these approaches demonstrated a superior rate of survival at day 90 when compared against the other strategy. This suggests that current guidelines advocating for aggressive or specific timing of both fluids and pressors might need re-evaluation in the acute setting.
This review discusses the ARISE-FLUIDS trial, which directly compared two distinct resuscitation strategies in septic shock patients presenting to the emergency department. One arm involved initiating vasopressors early alongside restricted fluid administration, while the other utilized higher initial fluid volumes with later vasopressor initiation. The primary finding reported is that neither of these approaches demonstrated a superior rate of survival at day 90 when compared against the other strategy. This suggests that current guidelines advocating for aggressive or specific timing of both fluids and pressors might need re-evaluation in the acute setting.
Show moreShow less
The ARISE-FLUIDS data suggest that aggressively titrating vasopressors early versus using higher initial fluid loads does not confer a survival advantage at day 90. When managing septic shock, remember that current resuscitation protocols should remain flexible; do not feel compelled to rigidly adhere to one specific timing sequence for initiating pressors or restricting fluids based on this trial alone.